Skip to content

PET probe guided extirpation of FDG-PET positive lymph nodes which are negative on other imaging modalities in head and neck cancer patients scheduled for primary irradiation

PET probe guided extirpation of FDG-PET positive lymph nodes which are negative on other imaging modalities in head and neck cancer patients scheduled for primary irradiation - PET probe guided extirpation of FDG-PET positive lymph nodes

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34841
Enrollment
20
Registered
2010-02-24
Start date
2009-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

FDG-PET/CT Lymph node extirpation under general anesthesia guide by PET-probe

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients with a primary biopsy proven head and neck cancer scheduled for primary irradiation with or without chemotherapy • Lymph nodes which are positive on FDG-PET but negative on other imaging modalities • Ultrasound guided fine needle aspiration cytology of these FDG-PET positive lymph nodes remains negative if performed after the results. This procedure must be performed afterwards if FDG-PET reveals these unexpected FDG-PET positive lymph nodes. • FDG-PET positive lymph nodes have impact on radiation treatment planning if based on FDG-PET as judged by the radiation oncologist. • *Informed consent* signed by patient

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Feasibility to extirpate these FDG-PET lymph nodes.

Secondary

MeasureTime frame
Diagnostic accuracy of PET-CT in these by other imaging techniques negative lymph nodes. Chance of radiation planning.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)